The Discounted Cash Flow (DCF) valuation of Thorne Healthtech Inc (THRN) is 7.92 USD. With the latest stock price at 10.19 USD, the upside of Thorne Healthtech Inc based on DCF is -22.3%.
Based on the latest price of 10.19 USD and our DCF valuation, Thorne Healthtech Inc (THRN) is a sell. selling THRN stocks now will result in a potential gain of 22.3%.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 9.2% | 7.8% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 5.08 - 17.53 | 7.92 |
| Upside | -50.2% - 72.0% | -22.3% |